Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese GP, DARTS/MEMO Collaboration: Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med 2005, 22: 749–755. 10.1111/j.1464-5491.2005.01501.x
Article
CAS
PubMed
Google Scholar
European Medicines Agency: Guideline on clinical investigation of medicinal products in the treatment of diabetes mellitus. (Last accessed February 2013) http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/10/WC500115945.pdf
Workgroup on Hypoglycemia. ADA: Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005, 28: 1245–1249.
Article
Google Scholar
Yale J-F, Begg I, Gerstein H, Houlden R, Jones H, Maheux P, Pacaud D: 2001 Canadian diabetes association clinical practice guidelines for the prevention and management of hypoglycemia in diabetes. Can J Diabetes 2001, 28: 22–35.
Google Scholar
Hepburn DA: Symptoms of hypoglycemia. In Hypoglycemia and diabetes: clinical and physiological aspects. Edited by: Frier BM. London: Edward Arnold; 1993.
Google Scholar
Alvarez-Guisasola F, Yin DD, Nocea G, Qiu Y, Mavros P: Association of hypoglycemic symptoms with patients’ rating of their health-related quality of life state: a cross sectional study. Health Qual Life Outcomes 2010, 8: 86. 10.1186/1477-7525-8-86
Article
PubMed Central
PubMed
Google Scholar
Brod M, Christiansen T, Thomsen TL, Bushnell DM: The impact of non-severe hypoglycaemic events on work productivity and diabetes management. Value Health 2011, 14: 665–671. 10.1016/j.jval.2011.02.001
Article
PubMed
Google Scholar
Polonsky WH, Davis CL, Jacobson AM, Anderson BJ: Correlates of hypoglycemic fear in type I and type II diabetes mellitus. Health Psychol 1992, 11: 199–202.
Article
CAS
PubMed
Google Scholar
Green AJ, Fox KM, Grandy S, SHIELD Study Group: Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus. Diabetes Res Clin Pract 2012, 96: 313–318. 10.1016/j.diabres.2012.01.002
Article
PubMed
Google Scholar
Barendse S, Singh H, Frier BM, Speight J: The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review. Diabet Med 2012, 29: 293–302. 10.1111/j.1464-5491.2011.03416.x
Article
CAS
PubMed
Google Scholar
Graveling AJ, Frier BM: Impaired awareness of hypoglycaemia: a review. Diabetes Metab 2010, 36: S64-S74.
Article
CAS
PubMed
Google Scholar
Clarke P, Gray A, Holman R: Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002, 22: 340–349.
Article
PubMed
Google Scholar
Weinstein MC, Torrance G, McGuire A: QALYs: the basics. Value Health 2009,12(Suppl 1):S5-S9.
Article
PubMed
Google Scholar
Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ: Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005, 21: 1477–1483. 10.1185/030079905X61929
Article
PubMed
Google Scholar
Lundkvist J, Berne C, Bolinder B, Jonsson L: The economic and quality of life impact of hypoglycaemia. Eur J Health Econ 2005, 6: 197–202. 10.1007/s10198-005-0276-3
Article
PubMed
Google Scholar
Currie CJ, Morgan CL, Poole CD, Sharplin P, Lammert M, McEwan P: Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Curr Med Res Opin 2006, 22: 1523–1534. 10.1185/030079906X115757
Article
PubMed
Google Scholar
Matza LS, Boye KS, Yurgin N, Brewster-Jordan J, Mannix S, Shorr JM, Barber BL: Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res 2007, 16: 1251–1265. 10.1007/s11136-007-9226-0
Article
PubMed
Google Scholar
Levy AR, Christensen TL, Johnson JA: Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom. Health Qual Life Outcomes 2008, 6: 73. 10.1186/1477-7525-6-73
Article
PubMed Central
PubMed
Google Scholar
Torrance GW, Furlong W, Feeny D: Health utility estimation. Expert Rev Pharmacoecon Outcomes Res 2002, 2: 99–108. 10.1586/14737167.2.2.99
Article
PubMed
Google Scholar
Torrance GW, Blaker D, Detsky A, Kennedy W, Schubert F, Menon D, Tugwell P, Konchak R, Hubbard E, Firestone T: Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics. Pharmacoeconomics 1996, 9: 535–539.
CAS
PubMed
Google Scholar
National Institute for Health and Clinical Excellence: Guide to the methods of technology appraisal. 2008. http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf
Google Scholar
Dolan P, Gudex C, Kind P, Williams A: The time trade-off method: results from a general population study. Health Econ 1996, 5: 141–154. 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N
Article
CAS
PubMed
Google Scholar
Dolan P: Modeling valuations for EuroQol health states. Med Care 1997, 35: 1095–1108. 10.1097/00005650-199711000-00002
Article
CAS
PubMed
Google Scholar
Dolan P, Jones-Lee M: The time trade-off: a note on the effect of lifetime reallocation of consumption and discounting. J Health Econ 1997, 16: 731–739. 10.1016/S0167-6296(96)00514-0
Article
CAS
PubMed
Google Scholar
Dolan P: The measurement of individual utility and social welfare. J Health Econ 1998, 17: 39–52. 10.1016/S0167-6296(97)00022-2
Article
CAS
PubMed
Google Scholar
Robinson A, Dolan P, Williams A: Valuing health status using VAS and TTO: what lies behind the numbers? Soc Sci Med 1997, 45: 1289–1297. 10.1016/S0277-9536(97)00057-9
Article
CAS
PubMed
Google Scholar
Torrance GW, Feeny D: Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989, 5: 559–575. 10.1017/S0266462300008461
Article
CAS
PubMed
Google Scholar
Torrance GW: Preferences for health outcomes and cost-utility analysis. Am J Manag Care 1997,3(Suppl 1):S8-S20.
PubMed
Google Scholar
Dolan P: Aggregating health state valuations. J Health Serv Res Policy 1997, 2: 160–165.
CAS
PubMed
Google Scholar
World Health Organization: Life tables for WHO member states. (Last accessed October 2012) http://apps.who.int/gho/data/node.main.687?lang=en
Szende A, Brazier J, Schaefer C, Deuson R, Isitt JJ, Vyas P: Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura. Curr Med Res Opin 2010, 26: 1893–1903. 10.1185/03007995.2010.494126
Article
PubMed
Google Scholar
Lieu TA, Ray GT, Ortega-Sanchez IR, Kleinman K, Rusinak D, Prosser LA: Willingness to pay for a QUALY based on community member and patient preferences for temporary health states associated with herpes zoster. PharmacoEconomics 2009, 27: 1005–1016. 10.2165/11314000-000000000-00000
Article
PubMed
Google Scholar
Chang WT, Collins ED, Kerrigan CL: An Internet-based utility assessment of breast hypertrophy. Plast Reconstr Surg 2001, 108: 370–377. 10.1097/00006534-200108000-00014
Article
CAS
PubMed
Google Scholar
Hurley J: An overview of the normative economics of the health sector. Chapter 2. In Cost-effectiveness in Health and Medicine. Edited by: Gold MR, Siegel JE, Russell LB, Weinstein MC. New York: Oxford University Press, Inc.; 1996:62–67.
Google Scholar
Dolan P: The measurement of health-related quality of life for use in resource allocation decisions in health care. Chapter 32. In Handbook of Health Economics. Edited by: Culyer AJ, Newhouse JP. Amsterdam: Elsevier (North Holland Publishing Co.); 2000:1738–1740.
Google Scholar
Gold MR, Patrick DL, Torrance GW, Fryback DG, Hadorn DC, Kamlet MS, Daniels N, Weinstein MC: Identifying and Valuing Outcomes. Chapter 4. In Cost-effectiveness in Health and Medicine. Edited by: Gold MR, Siegel JE, Russell LB, Weinstein MC. New York: Oxford University Press, Inc.; 1996:105–106.
Google Scholar
Briggs AH, Wonderling DE, Mooney CZ: Pulling cost-effectiveness up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997, 6: 327–340. 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W
Article
CAS
PubMed
Google Scholar
Atkinson SE, Wilson PW: Comparing mean efficiency and productivity scores from small samples: a bootstrap methodology. J Prod Anal 1995, 6: 137–152. 10.1007/BF01073408
Article
Google Scholar
Efron B: Nonparametric estimates of standard error: the jackknife, the bootstrap and other methods. Biometrika 1981, 68: 589–599. 10.1093/biomet/68.3.589
Article
Google Scholar
Attema AE, Brouwer WB: The value of correcting values: influence and importance of correcting TTO scores for time preference. Value Health 2010, 13: 879–884. 10.1111/j.1524-4733.2010.00773.x
Article
PubMed
Google Scholar
Central Intelligence Agency (CIA): The World Factbook: United Kingdom [Internet]. Washington, DC: CIA; 2012. (Last accessed October 2012) https://www.cia.gov/library/publications/the-world-factbook/geos/uk.html
Google Scholar
Fidler C, Elmelund Christensen T, Gillard S: Hypoglycaemia: an overview of fear of hypoglycaemia, quality-of-life, and impact on costs. J Med Econ 2011, 14: 646–655. 10.3111/13696998.2011.610852
Article
PubMed
Google Scholar
Jaeschke R, Singer J, Guyatt GH: Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989, 10: 407–415. 10.1016/0197-2456(89)90005-6
Article
CAS
PubMed
Google Scholar
Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK: Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 2006, 4: 70. 10.1186/1477-7525-4-70
Article
PubMed Central
PubMed
Google Scholar
Luo N, Johnson JA, Coons SJ: Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments. Med Care 2010, 48: 365–371. 10.1097/MLR.0b013e3181c162a2
Article
PubMed
Google Scholar
Pickard AS, Maureen P, Neary MP, Cella D: Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007, 5: 70. 10.1186/1477-7525-5-70
Article
PubMed Central
PubMed
Google Scholar
Walters SJ, Brazier JE: What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes 2003, 1: 4. 10.1186/1477-7525-1-4
Article
PubMed Central
PubMed
Google Scholar
Drummond M: Introducing economic and quality of life measurements into clinical studies. Ann Med 2001, 33: 344–349. 10.3109/07853890109002088
Article
CAS
PubMed
Google Scholar